Keyphrases
Cre Recombinase
100%
Oral Bioavailability
100%
Gut Metabolism
100%
Liver Metabolism
100%
Liver
66%
Cytochrome P450 1A1 (CYP1A1)
66%
Oxidative Metabolism
66%
Relative Contribution
33%
Cytotoxic Effect
33%
Pharmacokinetics
33%
Inducer
33%
Reductase
33%
Gene Promoter
33%
Cytochrome P450 Reductase
33%
Cytochrome P450 Monooxygenase
33%
Therapeutic Efficacy
33%
Xenobiotics
33%
3-methylcholanthrene
33%
Small Intestine
33%
Midazolam
33%
Drug Disposition
33%
Paroxetine
33%
Probe Drug
33%
Electron Donor
33%
Monooxygenase System
33%
Inducing Agents
33%
Targeted Deletion
33%
Oral Therapeutics
33%
Nelfinavir
33%
Intestinal Metabolism
33%
Floxed
33%
Biochemistry, Genetics and Molecular Biology
Metabolic Pathway
100%
Aerobic Metabolism
100%
Cre Recombinase
100%
Cytotoxicity
50%
Pharmacokinetics
50%
Oxidoreductase
50%
Reductase
50%
Gene Promoter
50%
Cytochrome P450 Reductase
50%
Unspecific Monooxygenase
50%
Low Drug Dose
50%
Small Intestine
50%
Drug Disposition
50%
Paroxetine
50%
Nelfinavir
50%
Cytochrome P450
50%
Midazolam
50%
Pharmacology, Toxicology and Pharmaceutical Science
Bioavailability
100%
Cre Recombinase
100%
Cytochrome P450 Reductase
33%
Cytochrome P450
33%
Combination Therapy
33%
Oxidoreductase
33%
Unspecific Monooxygenase
33%
Methylcholanthrene
33%
Midazolam
33%
Paroxetine
33%
Nelfinavir
33%
Cytotoxicity
33%
Pharmacokinetics
33%